Search results for "Diabetes"
USPSTF lowers age for starting diabetes screening from 40 to 35 years
Primary care clinicians should screen all overweight or obese adults ages 35 to 70 years for diabetes and prediabetes and should offer interventions for those with either condition, the U.S. Preventive Services Task Force (USPSTF) recently recommended.
https://immattersacp.org/weekly/archives/2021/08/31/2.htm
31 Aug 2021
Nocturnal hypoglycemia underdiagnosed in older patients on insulin for type 2 diabetes
An industry-funded study of patients ages 75 years and older who were taking insulin for type 2 diabetes found that almost two-thirds (65.2%) experienced nocturnal hypoglycemia during a 28-day study period.
https://immattersacp.org/weekly/archives/2023/04/04/1.htm
4 Apr 2023
Tailoring diabetes screening by race, ethnicity may lead to earlier diagnosis
Researchers used data from the National Health and Nutrition Examination Survey to determine the body mass index and age thresholds for diabetes screening in major racial/ethnic minority populations.
https://immattersacp.org/weekly/archives/2022/05/10/1.htm
10 May 2022
Large review compares benefits, harms of drugs to treat type 2 diabetes
High-certainty evidence indicated that sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists reduce all-cause death, while finerenone probably also reduced mortality based on moderate-certainty evidence.
https://immattersacp.org/weekly/archives/2023/04/18/4.htm
18 Apr 2023
KDIGO guideline summary provides key points for treating diabetes, chronic kidney disease
Authors from the Kidney Disease: Improving Global Outcomes (KDIGO) Work Group provided a synopsis of key recommendations on comprehensive care, glycemic monitoring and targets, lifestyle interventions, antihyperglycemic therapies, and educational and integrated care approaches.
https://immattersacp.org/weekly/archives/2023/01/10/1.htm
10 Jan 2023
Some newer diabetes drugs may help decrease risk of COPD exacerbation
A cohort study in the United Kingdom found that chronic obstructive pulmonary disease (COPD) exacerbations were less common in patients with type 2 diabetes and COPD taking glucagon-like peptide-1 receptor agonists or sodium-glucose cotransporter-2 inhibitors versus sulfonylureas.
https://immattersacp.org/weekly/archives/2022/11/08/4.htm
8 Nov 2022
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2023/10/latest-updates-on-acps-priorities-initiatives.htm
1 Oct 2023
Intensive blood pressure targets didn't reduce mortality in type 2 diabetes
Intensive hypertension treatment slightly reduced the risk of stroke in type 2 diabetics, but had no effect on mortality or myocardial infarction, a new review found.
https://immattersacp.org/weekly/archives/2012/08/14/6.htm
14 Aug 2012
Updated warnings on fluoroquinolones, new diabetes drug
This column reviews a warning on fluoroquinolones with a risk of disabling and potentially permanent side effects, as well as approval of an injection to improve glycemic control in adults with type 2 diabetes.
https://immattersacp.org/archives/2016/10/fda.htm
1 Oct 2016
Nearly 50% of older U.S. adults reported taking aspirin preventively
A study of National Health and Nutrition Examination Survey data from 2011 to 2018 found that 46.7% of respondents ages 60 years and older used aspirin for primary or secondary cardiovascular disease prevention and suggested potential overuse in certain groups.
https://immattersacp.org/weekly/archives/2021/06/29/4.htm
29 Jun 2021